Categories AlphaGraphs, Earnings, Health Care
LLY Earnings: Highlights of Eli Lilly’s Q2 2024 financial report
Eli Lilly and Company (NYSE: LLY) on Thursday reported a double-digit increase in revenues and profit for the second quarter of 2024. The pharma giant also raised its full-year guidance.
Worldwide revenue increased 36% annually to $11.3 billion in the June quarter, driven mainly by strong sales of Mounjaro, Zepbound, and Verzenio.
Second-quarter reported net income increased 68% from last year to $3.0 billion, or $3.8 per share. Adjusted earnings climbed 86% year-over-year to $3.92 per share.
The management raised its full-year revenue guidance to the range of $45.4 billion to $ 46.6 billion. EPS forecast and adjusted EPS forecast have been raised to $15.10-15.60 and $16.10-16.60, respectively.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Docusign (DOCU) Earnings: 3Q26 Key Numbers
Docusign, Inc. (NASDAQ: DOCU) reported its earnings results for the third quarter of 2026. Revenue increased 8% year-over-year to $818.4 million. GAAP net income was $83.7 million, or $0.40
Infographic: How Ulta Beauty (ULTA) performed in Q3 2025
Ulta Beauty, Inc. (NASDAQ: ULTA) reported its earnings results for the third quarter of 2025. Net sales increased 12.9% year-over-year to $2.9 billion, driven by comparable sales growth, the Space
Hewlett Packard Enterprise (HPE) Earnings: 4Q25 Key Numbers
Hewlett Packard Enterprise (NYSE: HPE) reported revenue of $9.7 billion for the fourth quarter of 2025, up 14% from the prior-year period in actual dollars and in constant currency. Net
